RNXT Insider Trading

Insider Ownership Percentage: 9.02%
Insider Buying (Last 12 Months): $21,276.26
Insider Selling (Last 12 Months): $0.00

RenovoRx Insider Trading History Chart

This chart shows the insider buying and selling history at RenovoRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

RenovoRx Share Price & Price History

Current Price: $1.96
Price Change: Price Increase of +0.16 (8.87%)
As of 12/6/2022 01:00 AM ET

This chart shows the closing price history over time for RNXT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

RenovoRx Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/7/2022Ramtin AgahInsiderBuy5,182$1.93$10,001.266,477View SEC Filing Icon  
5/19/2022Shaun BagaiCEOBuy5,500$2.05$11,275.00251,557View SEC Filing Icon  
See Full Table
Want To Catch The Next Hot Investing Trend (Look Inside?)
While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...
And It Could Spark An Economic Boom For Investors

SEC Filings (Institutional Ownership Changes) for RenovoRx (NASDAQ:RNXT)

13.11% of RenovoRx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RNXT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

RenovoRx Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Colony Group LLC15,741$32K0.0%N/A0.174%Search for SEC Filing on Google Icon
11/10/2022Cohen Lawrence B54,121$0.16M0.1%-44.3%0.597%Search for SEC Filing on Google Icon
8/11/2022Cohen Lawrence B97,165$0.19M0.1%+79.5%1.072%Search for SEC Filing on Google Icon
8/2/2022Bank of The West975,000$1.93M0.2%N/A10.750%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE14,802$44K0.0%N/A0.163%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.10,815$32K0.0%N/A0.120%Search for SEC Filing on Google Icon
5/13/2022Cohen Lawrence B54,121$0.16M0.1%N/A0.599%Search for SEC Filing on Google Icon
2/3/2022Cambridge Investment Research Advisors Inc.14,400$70K0.0%-64.7%0.162%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC20,569$0.13M0.0%N/A0.245%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Securities LLC17,944$0.11M0.0%N/A0.214%Search for SEC Filing on Google Icon
11/12/2021Board of Trustees of The Leland Stanford Junior University60,863$0.37M0.0%N/A0.726%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.40,850$0.25M0.0%N/A0.487%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
RenovoRx logo
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
Read More on RenovoRx

Today's Range

Now: $1.96
Low: $1.50
High: $2.09

50 Day Range

MA: $1.87
Low: $1.65
High: $2.11

52 Week Range

Now: $1.96
Low: $1.50
High: $6.87

Volume

71,349 shs

Average Volume

4,170 shs

Market Capitalization

$17.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53

Who are the company insiders with the largest holdings of RenovoRx?

RenovoRx's top insider shareholders include:
  1. Shaun Bagai (CEO)
  2. Ramtin Agah (Insider)
Learn More about top insider investors at RenovoRx.

Who are the major institutional investors of RenovoRx?

RenovoRx's top institutional investors include:
  1. Cohen Lawrence B — 0.60%
  2. Colony Group LLC — 0.17%
Learn More about top institutional investors of RenovoRx stock.

Which major investors are selling RenovoRx stock?

During the previous quarter, RNXT stock was sold by these institutional investors:
  1. Cohen Lawrence B

Which major investors are buying RenovoRx stock?

Within the last quarter, RNXT stock was bought by institutional investors including:
  1. Colony Group LLC
During the previous year, these company insiders have bought RenovoRx stock:
  1. Shaun Bagai (CEO)
  2. Ramtin Agah (Insider)
Learn More investors buying RenovoRx stock.